Annual FCF
-$13.49 M
-$645.30 K-5.02%
December 31, 2023
Summary
- As of February 7, 2025, POAI annual free cash flow is -$13.49 million, with the most recent change of -$645.30 thousand (-5.02%) on December 31, 2023.
- During the last 3 years, POAI annual FCF has fallen by -$873.30 thousand (-6.92%).
- POAI annual FCF is now -1543.94% below its all-time high of -$820.70 thousand, reached on December 31, 2010.
Performance
POAI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.28 M
+$945.00 K+29.31%
September 30, 2024
Summary
- As of February 7, 2025, POAI quarterly free cash flow is -$2.28 million, with the most recent change of +$945.00 thousand (+29.31%) on September 30, 2024.
- Over the past year, POAI quarterly FCF has increased by +$945.00 thousand (+29.31%).
- POAI quarterly FCF is now -17570.54% below its all-time high of -$12.90 thousand, reached on March 31, 2015.
Performance
POAI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$13.29 M
-$463.90 K-3.62%
September 30, 2024
Summary
- As of February 7, 2025, POAI TTM free cash flow is -$13.29 million, with the most recent change of -$463.90 thousand (-3.62%) on September 30, 2024.
- Over the past year, POAI TTM FCF has dropped by -$463.90 thousand (-3.62%).
- POAI TTM FCF is now -3849.93% below its all-time high of -$336.50 thousand, reached on March 31, 2009.
Performance
POAI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
POAI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | +29.3% | -3.6% |
| 3 y3 years | -6.9% | +40.5% | +1.2% |
| 5 y5 years | -144.4% | +40.5% | +1.2% |
POAI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.0% | at low | -25.6% | +47.8% | -7.0% | +3.0% |
| 5 y | 5-year | -54.0% | at low | -25.6% | +47.8% | -51.8% | +3.0% |
| alltime | all time | -1543.9% | at low | <-9999.0% | +48.6% | -3849.9% | +3.0% |
Predictive Oncology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.28 M(-29.3%) | -$13.29 M(+3.6%) |
| Jun 2024 | - | -$3.22 M(-5.7%) | -$12.83 M(-4.5%) |
| Mar 2024 | - | -$3.42 M(-21.7%) | -$13.44 M(-0.4%) |
| Dec 2023 | -$13.49 M(+5.0%) | -$4.37 M(+140.6%) | -$13.49 M(+8.6%) |
| Sep 2023 | - | -$1.82 M(-52.6%) | -$12.42 M(-7.7%) |
| Jun 2023 | - | -$3.83 M(+10.3%) | -$13.46 M(+2.4%) |
| Mar 2023 | - | -$3.47 M(+5.3%) | -$13.15 M(+2.3%) |
| Dec 2022 | -$12.85 M(-2.5%) | -$3.30 M(+15.7%) | -$12.85 M(-4.8%) |
| Sep 2022 | - | -$2.85 M(-19.0%) | -$13.49 M(-1.6%) |
| Jun 2022 | - | -$3.52 M(+11.0%) | -$13.71 M(+8.5%) |
| Mar 2022 | - | -$3.17 M(-19.5%) | -$12.63 M(-4.1%) |
| Dec 2021 | -$13.17 M(+4.4%) | -$3.94 M(+28.4%) | -$13.17 M(+12.2%) |
| Sep 2021 | - | -$3.07 M(+25.5%) | -$11.73 M(-2.3%) |
| Jun 2021 | - | -$2.45 M(-34.2%) | -$12.01 M(-9.9%) |
| Mar 2021 | - | -$3.72 M(+48.3%) | -$13.33 M(+5.6%) |
| Dec 2020 | -$12.62 M(+44.1%) | -$2.50 M(-25.2%) | -$12.62 M(-2.3%) |
| Sep 2020 | - | -$3.35 M(-10.9%) | -$12.92 M(+12.6%) |
| Jun 2020 | - | -$3.76 M(+25.1%) | -$11.47 M(+18.1%) |
| Mar 2020 | - | -$3.01 M(+7.2%) | -$9.71 M(+10.9%) |
| Dec 2019 | -$8.76 M(+58.7%) | -$2.80 M(+47.5%) | -$8.76 M(+21.8%) |
| Sep 2019 | - | -$1.90 M(-5.0%) | -$7.19 M(+14.0%) |
| Jun 2019 | - | -$2.00 M(-2.4%) | -$6.31 M(+8.4%) |
| Mar 2019 | - | -$2.05 M(+66.3%) | -$5.82 M(+5.4%) |
| Dec 2018 | -$5.52 M(+22.3%) | -$1.23 M(+20.9%) | -$5.52 M(-1.7%) |
| Sep 2018 | - | -$1.02 M(-32.6%) | -$5.61 M(-1.0%) |
| Jun 2018 | - | -$1.51 M(-13.5%) | -$5.67 M(+11.5%) |
| Mar 2018 | - | -$1.75 M(+32.0%) | -$5.08 M(+12.6%) |
| Dec 2017 | -$4.51 M(+2.0%) | -$1.33 M(+23.1%) | -$4.52 M(+16.5%) |
| Sep 2017 | - | -$1.08 M(+16.2%) | -$3.88 M(+4.0%) |
| Jun 2017 | - | -$927.40 K(-21.6%) | -$3.73 M(-6.8%) |
| Mar 2017 | - | -$1.18 M(+71.9%) | -$4.00 M(-9.6%) |
| Dec 2016 | -$4.43 M | -$688.20 K(-26.0%) | -$4.43 M(-33.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$929.80 K(-22.6%) | -$6.62 M(-34.6%) |
| Jun 2016 | - | -$1.20 M(-25.2%) | -$10.13 M(+10.9%) |
| Mar 2016 | - | -$1.61 M(-44.3%) | -$9.14 M(+21.1%) |
| Dec 2015 | -$7.55 M(+116.1%) | -$2.89 M(-35.0%) | -$7.55 M(+54.4%) |
| Sep 2015 | - | -$4.44 M(+2019.8%) | -$4.89 M(+190.9%) |
| Jun 2015 | - | -$209.40 K(+1523.3%) | -$1.68 M(+0.8%) |
| Mar 2015 | - | -$12.90 K(-94.3%) | -$1.67 M(-52.3%) |
| Dec 2014 | -$3.49 M(-14.2%) | -$227.70 K(-81.5%) | -$3.49 M(-10.4%) |
| Sep 2014 | - | -$1.23 M(+529.0%) | -$3.90 M(-0.7%) |
| Jun 2014 | - | -$195.60 K(-89.4%) | -$3.92 M(-21.0%) |
| Mar 2014 | - | -$1.84 M(+190.4%) | -$4.97 M(+22.1%) |
| Dec 2013 | -$4.07 M(+243.8%) | -$633.30 K(-49.6%) | -$4.07 M(+6.0%) |
| Sep 2013 | - | -$1.26 M(+1.2%) | -$3.84 M(+41.2%) |
| Jun 2013 | - | -$1.24 M(+32.0%) | -$2.72 M(+45.2%) |
| Mar 2013 | - | -$940.30 K(+133.0%) | -$1.87 M(+58.3%) |
| Dec 2012 | -$1.18 M(-33.5%) | -$403.50 K(+195.4%) | -$1.18 M(-14.0%) |
| Sep 2012 | - | -$136.60 K(-65.3%) | -$1.38 M(-14.9%) |
| Jun 2012 | - | -$393.90 K(+57.4%) | -$1.62 M(-2.8%) |
| Mar 2012 | - | -$250.20 K(-58.0%) | -$1.66 M(-6.6%) |
| Dec 2011 | -$1.78 M(+117.1%) | -$595.70 K(+57.6%) | -$1.78 M(+44.4%) |
| Sep 2011 | - | -$378.10 K(-14.1%) | -$1.23 M(+13.2%) |
| Jun 2011 | - | -$440.40 K(+19.9%) | -$1.09 M(+22.1%) |
| Mar 2011 | - | -$367.40 K(+671.8%) | -$892.80 K(+8.8%) |
| Dec 2010 | -$820.70 K(-37.4%) | -$47.60 K(-79.7%) | -$820.70 K(-25.2%) |
| Sep 2010 | - | -$234.60 K(-3.5%) | -$1.10 M(-3.9%) |
| Jun 2010 | - | -$243.20 K(-17.6%) | -$1.14 M(-10.0%) |
| Mar 2010 | - | -$295.30 K(-9.0%) | -$1.27 M(-3.1%) |
| Dec 2009 | -$1.31 M(+39.0%) | -$324.50 K(+16.5%) | -$1.31 M(+32.9%) |
| Sep 2009 | - | -$278.60 K(-24.8%) | -$985.50 K(+39.4%) |
| Jun 2009 | - | -$370.40 K(+10.1%) | -$706.90 K(+110.1%) |
| Mar 2009 | - | -$336.50 K | -$336.50 K |
| Dec 2008 | -$942.40 K | - | - |
FAQ
- What is Predictive Oncology annual free cash flow?
- What is the all time high annual FCF for Predictive Oncology?
- What is Predictive Oncology annual FCF year-on-year change?
- What is Predictive Oncology quarterly free cash flow?
- What is the all time high quarterly FCF for Predictive Oncology?
- What is Predictive Oncology quarterly FCF year-on-year change?
- What is Predictive Oncology TTM free cash flow?
- What is the all time high TTM FCF for Predictive Oncology?
- What is Predictive Oncology TTM FCF year-on-year change?
What is Predictive Oncology annual free cash flow?
The current annual FCF of POAI is -$13.49 M
What is the all time high annual FCF for Predictive Oncology?
Predictive Oncology all-time high annual free cash flow is -$820.70 K
What is Predictive Oncology annual FCF year-on-year change?
Over the past year, POAI annual free cash flow has changed by -$645.30 K (-5.02%)
What is Predictive Oncology quarterly free cash flow?
The current quarterly FCF of POAI is -$2.28 M
What is the all time high quarterly FCF for Predictive Oncology?
Predictive Oncology all-time high quarterly free cash flow is -$12.90 K
What is Predictive Oncology quarterly FCF year-on-year change?
Over the past year, POAI quarterly free cash flow has changed by +$945.00 K (+29.31%)
What is Predictive Oncology TTM free cash flow?
The current TTM FCF of POAI is -$13.29 M
What is the all time high TTM FCF for Predictive Oncology?
Predictive Oncology all-time high TTM free cash flow is -$336.50 K
What is Predictive Oncology TTM FCF year-on-year change?
Over the past year, POAI TTM free cash flow has changed by -$463.90 K (-3.62%)